Rational design of potent sialidase-based inhibitors of influenza virus replication.

Article Details

Citation
Copy to clipboard

von Itzstein M, Wu WY, Kok GB, Pegg MS, Dyason JC, Jin B, Van Phan T, Smythe ML, White HF, Oliver SW, et al.

Rational design of potent sialidase-based inhibitors of influenza virus replication.

Nature. 1993 Jun 3;363(6428):418-23.

PubMed ID
8502295 [ View in PubMed
]
Abstract

Two potent inhibitors based on the crystal structure of influenza virus sialidase have been designed. These compounds are effective inhibitors not only of the enzyme, but also of the virus in cell culture and in animal models. The results provide an example of the power of rational, computer-assisted drug design, as well as indicating significant progress in the development of a new therapeutic or prophylactic treatment for influenza infection.

DrugBank Data that Cites this Article

Drugs